Faruqi & Faruqi, LLP Announces Investigation of Columbia Laboratories Inc. (CBRX)
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Columbia Laboratories Inc. (“Columbia” or the “Company”) (Nasdaq: CBRX).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) the Company’s PROCHIEVE product was not delivering desired results; (2) the Food & Drug Administration (“FDA”) was unlikely to give approval to Columbia’s PROCHIEVE product; and (3) contrary to Company representations, Columbia’s future was not “very good” due to the efficacy issues with PROCHIEVE.
Columbia’s much touted product “PROCHIEVE” is a gel intended to prevent preterm births. On December 14, 2011, the Company issued a press release highlighting the purported results of clinical trials that showed that PROCHIEVE “significantly reduces the risk of preterm birth and neonatal morbidity.” Following this announcement, Columbia’s stock increased in price significantly.
On January 17, 2012, however, the FDA released documents, including trial data, which evidenced PROCHIEVE’s ineffectiveness. As a result, Columbia’s stock price plunged by over 50%, to $1.10. Then, on January 20, 2012, the FDA Advisory Committee voted 13 to 4 against recommending PROCHIEVE, as the potential risks of the progesterone gel outweighed the benefits. As a result, Columbia’s shares declined by an additional $0.874 per share to close at $0.706 per share on January 23, 2012.
If you purchased Columbia securities between December 6, 2010 and January 20, 2012 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Columbia’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.